Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat.

Lohan P, Treacy O, Morcos M, Donohoe E, O'donoghue Y, Ryan AE, Elliman SJ, Ritter T, Griffin MD.

Stem Cells. 2018 Aug;36(8):1210-1215. doi: 10.1002/stem.2840. Epub 2018 May 16.

PMID:
29726063
2.

Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.

Lohan P, Murphy N, Treacy O, Lynch K, Morcos M, Chen B, Ryan AE, Griffin MD, Ritter T.

Front Immunol. 2018 Nov 20;9:2666. doi: 10.3389/fimmu.2018.02666. eCollection 2018.

3.

Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.

Jia Z, Jiao C, Zhao S, Li X, Ren X, Zhang L, Han ZC, Zhang X.

Exp Eye Res. 2012 Sep;102:44-9. doi: 10.1016/j.exer.2012.06.008. Epub 2012 Jul 16.

PMID:
22800963
4.

Immunomodulatory effects of bone marrow-derived mesenchymal stem cells on pro-inflammatory cytokine-stimulated human corneal epithelial cells.

Wen L, Zhu M, Madigan MC, You J, King NJ, Billson FA, McClellan K, Sutton G, Petsoglou C.

PLoS One. 2014 Jul 8;9(7):e101841. doi: 10.1371/journal.pone.0101841. eCollection 2014.

5.

TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung.

Murphy N, Treacy O, Lynch K, Morcos M, Lohan P, Howard L, Fahy G, Griffin MD, Ryan AE, Ritter T.

FASEB J. 2019 May 20:fj201900047R. doi: 10.1096/fj.201900047R. [Epub ahead of print]

PMID:
31108041
6.

Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation.

Sivanathan KN, Gronthos S, Rojas-Canales D, Thierry B, Coates PT.

Stem Cell Rev. 2014 Jun;10(3):351-75. doi: 10.1007/s12015-014-9495-2. Review.

PMID:
24510581
7.

Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.

Roemeling-van Rhijn M, Khairoun M, Korevaar SS, Lievers E, Leuning DG, Ijzermans JN, Betjes MG, Genever PG, van Kooten C, de Fijter HJ, Rabelink TJ, Baan CC, Weimar W, Roelofs H, Hoogduijn MJ, Reinders ME.

J Stem Cell Res Ther. 2013 Nov 25;Suppl 6(1):20780.

8.

Mesenchymal stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation.

Murphy N, Lynch K, Lohan P, Treacy O, Ritter T.

Curr Opin Organ Transplant. 2016 Dec;21(6):559-567. Review.

PMID:
27801687
9.

Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.

de Witte SFH, Merino AM, Franquesa M, Strini T, van Zoggel JAA, Korevaar SS, Luk F, Gargesha M, O'Flynn L, Roy D, Elliman SJ, Newsome PN, Baan CC, Hoogduijn MJ.

Stem Cell Res Ther. 2017 Jun 8;8(1):140. doi: 10.1186/s13287-017-0590-6.

10.

Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.

Sbano P, Cuccia A, Mazzanti B, Urbani S, Giusti B, Lapini I, Rossi L, Abbate R, Marseglia G, Nannetti G, Torricelli F, Miracco C, Bosi A, Fimiani M, Saccardi R.

Arch Dermatol Res. 2008 Mar;300(3):115-24. doi: 10.1007/s00403-007-0827-9. Epub 2008 Feb 8.

PMID:
18259766
11.

Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.

Pigott JH, Ishihara A, Wellman ML, Russell DS, Bertone AL.

Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):99-106. doi: 10.1016/j.vetimm.2013.09.003. Epub 2013 Sep 18.

PMID:
24094688
12.

Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.

Blanco B, Herrero-Sánchez MD, Rodríguez-Serrano C, García-Martínez ML, Blanco JF, Muntión S, García-Arranz M, Sánchez-Guijo F, Del Cañizo C.

Eur J Haematol. 2016 Dec;97(6):528-537. doi: 10.1111/ejh.12765. Epub 2016 Jun 1.

PMID:
27118602
13.

Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.

Inoue S, Popp FC, Koehl GE, Piso P, Schlitt HJ, Geissler EK, Dahlke MH.

Transplantation. 2006 Jun 15;81(11):1589-95.

PMID:
16770249
14.

Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase.

Zinöcker S, Vaage JT.

Front Immunol. 2012 Apr 2;3:62. doi: 10.3389/fimmu.2012.00062. eCollection 2012.

15.

In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants.

Hoornaert CJ, Luyckx E, Reekmans K, Dhainaut M, Guglielmetti C, Le Blon D, Dooley D, Fransen E, Daans J, Verbeeck L, Quarta A, De Vocht N, Lemmens E, Goossens H, Van der Linden A, Roobrouck VD, Verfaillie C, Hendrix S, Moser M, Berneman ZN, Ponsaerts P.

Stem Cells. 2016 Jul;34(7):1971-84. doi: 10.1002/stem.2360. Epub 2016 Mar 28.

16.

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

Perico N, Casiraghi F, Gotti E, Introna M, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Noris M, Remuzzi G.

Transpl Int. 2013 Sep;26(9):867-78. doi: 10.1111/tri.12132. Epub 2013 Jun 6.

17.

Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation.

Treacy O, O'Flynn L, Ryan AE, Morcos M, Lohan P, Schu S, Wilk M, Fahy G, Griffin MD, Nosov M, Ritter T.

Am J Transplant. 2014 Sep;14(9):2023-36. doi: 10.1111/ajt.12828. Epub 2014 Aug 6.

18.

Adipose-derived mesenchymal stem cell administration does not improve corneal graft survival outcome.

Fuentes-Julián S, Arnalich-Montiel F, Jaumandreu L, Leal M, Casado A, García-Tuñon I, Hernández-Jiménez E, López-Collazo E, De Miguel MP.

PLoS One. 2015 Mar 2;10(3):e0117945. doi: 10.1371/journal.pone.0117945. eCollection 2015.

19.

Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.

Kadle RL, Abdou SA, Villarreal-Ponce AP, Soares MA, Sultan DL, David JA, Massie J, Rifkin WJ, Rabbani P, Ceradini DJ.

PLoS One. 2018 Mar 7;13(3):e0193178. doi: 10.1371/journal.pone.0193178. eCollection 2018.

20.

Stem cells isolated from the human stromal limbus possess immunosuppressant properties.

Garfias Y, Nieves-Hernandez J, Garcia-Mejia M, Estrada-Reyes C, Jimenez-Martinez MC.

Mol Vis. 2012;18:2087-95. Epub 2012 Jul 25.

Supplemental Content

Support Center